Government of Canada and JDRF Canada announce new research funding to accelerate stem cell-based therapies for type 1 diabetes
November 28, 2020 — Ottawa, ON — Canadian Institutes of Health Research To mark the end of Diabetes Awareness Month, Sonia Sidhu, ...Read More
JDRF and our T1D Heroes feel that Manitoba should follow the lead of Alberta, Ontario, Nunavut, North West Territories, and Yukon – provinces and territories which already cover insulin pump costs for all residents.
Ford Motor Company and JDRF Canada are pleased to announce that Ford Windsor Operations has raised a cumulative total of over $1 million for the JDRF TELUS Walk to Cure Diabetes.
JDRF and Diabetes Canada join together to propose a solution for Canadians with diabetes on the Disability Tax Credit
JDRF Canada and Diabetes Canada sent a joint letter to The Honourable Diane Lebouthillier, Minister of National Revenue yesterday outlining their proposed solution to the issue of access to the Disability Tax Credit (DTC) for people with type 1 diabetes.
Letter from JDRF and Diabetes Canada to the Honourable Diane Lebouthillier regarding joint recommendations aimed at ensuring access to the Disability Tax Credit for Canadians with diabetes
We are writing to you with regard to the ability of people with diabetes to access the Disability Tax Credit.
JDRF-Funded Study on Continuous Glucose Monitoring (CGM) in Pregnant Women with Type 1 Diabetes Shows Improved Outcomes for Their Newborns
Babies born to women with type 1 diabetes (T1D) may soon be at a reduced risk of complications after a JDRF-funded study revealed that observing blood sugar levels via a continuous glucose monitor (CGM) throughout pregnancy leads to better glycemic control for mothers and healthier outcomes for thei...
JDRF advocates for all Canadians living with type 1 diabetes to be eligible for the Disability Tax Credit
JDRF believes that every Canadian with type 1 diabetes should qualify for the Disability Tax Credit.
The JDRF Revolution Ride challenges Canadians to go further and raise funds to defeat type 1 diabetes.
Eli Lilly Canada Inc. (Lilly Canada) and JDRF Canada have awarded two promising researchers each with a post-doctoral fellowship grant to pursue studies in type 1 diabetes.
JDRF has awarded Dr. James Johnson and his team from the University of British Columbia (UBC) a grant of US$150,000 for a one-year study on whether insulin levels produced by transplanted pancreatic beta cells can be controlled and stabilized.
JDRF and Lilly Canada fund UHN research on new stem cell therapies aimed at eliminating the need for insulin injections.